The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2
Open accessAbstract
Liver disease is one of the leading causes of death worldwide. Patients with cirrhosis display an increased predisposition to and mortality from infection due to multimodal defects in the innate immune system; however, the causative mechanism has remained elusive. We present evidence that the cyclooxygenase (COX)-derived eicosanoid prostaglandin E2 (PGE2) drives cirrhosis-associated immunosuppression. We observed elevated circulating concentrations (more than seven times as high as in healthy volunteers) of PGE2 in patients with acute decompensation of cirrhosis. Plasma from these and patients with end-stage liver disease (ESLD) suppressed macrophage proinflammatory cytokine secretion and bacterial killing in vitro in a PGE2-dependent manner via the prostanoid type E receptor-2 (EP2), effects not seen with plasma from patients with stable cirrhosis (Child-Pugh score grade A). Albumin, which reduces PGE2 bioavailability, was decreased in the serum of patients with acute decompensation or ESLD (<30 mg/dl) and appears to have a role in modulating PGE2-mediated immune dysfunction. In vivo administration of human albumin solution to these patients significantly improved the plasma-induced impairment of macrophage proinflammatory cytokine production in vitro. Two mouse models of liver injury (bile duct ligation and carbon tetrachloride) also exhibited elevated PGE2, reduced circulating albumin concentrations and EP2-mediated immunosuppression. Treatment with COX inhibitors or albumin restored immune competence and survival following infection with group B Streptococcus. Taken together, human albumin solution infusions may be used to reduce circulating PGE2 levels, attenuating immune suppression and reducing the risk of infection in patients with acutely decompensated cirrhosis or ESLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moreau, R., Jalan, R., Gines, P., Pavesi, M., Angeli, P., Cordoba, J., Durand, F., Gustot, T., Saliba, F., Domenicali, M., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.042 · Cited by 3,020
Self-citationSort, P., Navasa, M., Arroyo, V., Aldeguer, X., Planas, R., Ruiz-del-Arbol, L., Castells, L., Vargas, V., Soriano, G., Guevara, M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410603 · Cited by 1,654
Regulation of Immune Responses by Prostaglandin E2
Kalinski, P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101029 · Cited by 1,474
Fernández, J., Navasa, M., Gómez, J., Colmenero, J., Vila, J., Arroyo, V., & Rodés, J. (2002) · Hepatology · doi:10.1053/jhep.2002.30082 · Cited by 954
Runyon, B. A. (2013) · Hepatology · doi:10.1002/hep.26359 · Cited by 778
Fernández, J., Acevedo, J., Castro, M., Garcia, O., de Lope, C. R., Roca, D., Pavesi, M., Sola, E., Moreira, L., Silva, A., et al. (2012) · Hepatology · doi:10.1002/hep.25532 · Cited by 620
Patients with acute on chronic liver failure display ‘sepsis-like’ immune paralysis
Wasmuth, H. E., Kunz, D., Yagmur, E., Timmer-Stranghöner, A., Vidacek, D., Siewert, E., Bach, J., Geier, A., Purucker, E. A., Gressner, A. M., et al. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.10.019 · Cited by 539
Albumin: Pathophysiologic basis of its role in the treatment of cirrhosis and its complications
Garcia-Martinez, R., Caraceni, P., Bernardi, M., Gines, P., Arroyo, V., & Jalan, R. (2013) · Hepatology · doi:10.1002/hep.26338 · Cited by 471
Self-citationCyclic AMP: Master Regulator of Innate Immune Cell Function
Serezani, C. H., Ballinger, M. N., Aronoff, D. M., & Peters-Golden, M. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0091tr · Cited by 415
Smith, A. M., Rahman, F. Z., Hayee, B., Graham, S. J., Marks, D. J. B., Sewell, G. W., Palmer, C. D., Wilde, J., Foxwell, B. M. J., Gloger, I. S., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20091233 · Cited by 398
Self-citationAronoff, D. M., Canetti, C., & Peters-Golden, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.559 · Cited by 360
Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome
Hall, M. W., Knatz, N. L., Vetterly, C., Tomarello, S., Wewers, M. D., Volk, H. D., & Carcillo, J. A. (2011) · Intensive Care Medicine · doi:10.1007/s00134-010-2088-x · Cited by 355
Old and new generation lipid mediators in acute inflammation and resolution
Stables, M. J., & Gilroy, D. W. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.07.005 · Cited by 334
Self-citationMookerjee, R. P., Stadlbauer, V., Lidder, S., Wright, G. A. K., Hodges, S. J., Davies, N. A., & Jalan, R. (2007) · Hepatology · doi:10.1002/hep.21737 · Cited by 332
The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease
Lim, Y.-S., & Kim, W. R. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.007 · Cited by 316
Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding
Chavez-Tapia, N. C., Barrientos-Gutierrez, T., Tellez-Avila, F. I., Soares-Weiser, K., & Uribe, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002907.pub2 · Cited by 304
Rajkovic, I. A., & Williams, R. (1986) · Hepatology · doi:10.1002/hep.1840060217 · Cited by 270
The Anti-Inflammatory Effects of Prostaglandins
Scher, J. U., & Pillinger, M. H. (2009) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e31819aaa76 · Cited by 259
Characterization of time-related changes after experimental bile duct ligation
Georgiev, P., Jochum, W., Heinrich, S., Jang, J. H., Nocito, A., Dahm, F., & Clavien, P.-A. (2008) · British Journal of Surgery · doi:10.1002/bjs.6050 · Cited by 249
Ammonia impairs neutrophil phagocytic function in liver disease†
Shawcross, D. L., Wright, G. A. K., Stadlbauer, V., Hodges, S. J., Davies, N. A., Wheeler‐Jones, C., Pitsillides, A. A., & Jalan, R. (2008) · Hepatology · doi:10.1002/hep.22474 · Cited by 170
Prostaglandin E 2 Suppresses Bacterial Killing in Alveolar Macrophages by Inhibiting NADPH Oxidase
Serezani, C. H., Chung, J., Ballinger, M. N., Moore, B. B., Aronoff, D. M., & Peters-Golden, M. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0153oc · Cited by 166
Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE2/EP2 signaling
Medeiros, A. I., Serezani, C. H., Lee, S. P., & Peters-Golden, M. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082058 · Cited by 159
Romanelli, R. G. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i9.1403 · Cited by 155
Prostaglandin E2 and the Pathogenesis of Pulmonary Fibrosis
Bozyk, P. D., & Moore, B. B. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0025rt · Cited by 152
Masoodi, M., Mir, A. A., Petasis, N. A., Serhan, C. N., & Nicolaou, A. (2007) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.3331 · Cited by 143
Self-citationA novel model of CCl4-induced cirrhosis with ascites in the mouse
Domenicali, M., Caraceni, P., Giannone, F. A., Baldassarre, M., Lucchetti, G., Quarta, C., Patti, C., Catani, L., Nanni, C., Lemoli, R. M., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.09.008 · Cited by 133
McAnulty, R. J., Hernández-Rodríguez, N. A., Mutsaers, S. E., Coker, R. K., & Laurent, G. J. (1997) · Biochemical Journal · doi:10.1042/bj3210639 · Cited by 114
GREEN TEA POLYPHENOL EXTRACT ATTENUATES ZYMOSAN-INDUCED NON-SEPTIC SHOCK IN MICE
Paola, R. D., Mazzon, E., Muià, C., Crisafulli, C., Genovese, T., Bella, P. D., Esposito, E., Menegazzi, M., Meli, R., Suzuki, H., et al. (2006) · Shock · doi:10.1097/01.shk.0000191379.62897.1d · Cited by 109
Interleukin-10 and its role in clinical immunoparalysis following pediatric cardiac surgery*
Allen, M. L., Hoschtitzky, J. A., Peters, M. J., Elliott, M. J., Goldman, A. P., James, I., & Klein, N. J. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000240243.28129.36 · Cited by 101
Laleman, W., Verbeke, L., Meersseman, P., Wauters, J., van Pelt, J. F., Cassiman, D. M., Wilmer, A. P., Verslype, C., & Nevens, F. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.47 · Cited by 98
O'Brien, A. J., Welch, C. A., Singer, M., & Harrison, D. A. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2523-2 · Cited by 90
Self-citationLipid mediators in immune dysfunction after severe inflammation
Fullerton, J. N., O'Brien, A. J., & Gilroy, D. W. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.10.008 · Cited by 87
Self-citationPathways mediating resolution of inflammation: when enough is too much
Fullerton, J. N., O'Brien, A. J., & Gilroy, D. W. (2013) · The Journal of Pathology · doi:10.1002/path.4232 · Cited by 84
Self-citationImpaired monocyte function in liver cirrhosis.
Hassner, A., Kletter, Y., Shlag, D., Yedvab, M., Aronson, M., & Shibolet, S. (1981) · BMJ · doi:10.1136/bmj.282.6272.1262 · Cited by 75
Carbamylated albumin is a potent inhibitor of polymorphonuclear neutrophil respiratory burst
Jaisson, S., Delevallée-Forte, C., Touré, F., Rieu, P., Garnotel, R., & Gillery, P. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.03.008 · Cited by 61
Management of infections in cirrhotic patients: Report of a Consensus Conference
FAGIUOLI, S., Colli, A., Bruno, R., Burra, P., Craxì, A., Gaeta, G. B., Grossi, P., Mondelli, M. U., Puoti, M., Sagnelli, E., et al. (2013) · Digestive and Liver Disease · doi:10.1016/j.dld.2013.07.015 · Cited by 50
Cohen, M. J., Sahar, T., Benenson, S., Elinav, E., Brezis, M., & Soares‐Weiser, K. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004791.pub2 · Cited by 44
Bourdonnay, E., Serezani, C. H., Aronoff, D. M., & Peters-Golden, M. L. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.1211590 · Cited by 27
Prostaglandin E2 Production During Hepatic Regeneration Downregulates Kupffer Cell IL-6 Production
Goss, J. A., Mangino, M. J., & Flye, M. W. (1992) · Annals of Surgery · doi:10.1097/00000658-199206000-00001 · Cited by 21
Cited by
Resolution of inflammation: a new therapeutic frontier
Fullerton, J. N., & Gilroy, D. W. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.39 · Cited by 937
Self-citationThe Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer
Affo, S., Yu, L.-X., & Schwabe, R. F. (2017) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100322 · Cited by 757
Mechanisms of Organ Injury and Repair by Macrophages
Vannella, K. M., & Wynn, T. A. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034356 · Cited by 656
Acute-on-chronic liver failure: an update
Hernaez, R., Solà, E., Moreau, R., & Ginès, P. (2017) · Gut · doi:10.1136/gutjnl-2016-312670 · Cited by 605
Fernández, J., Acevedo, J., Wiest, R., Gustot, T., Amoros, A., Deulofeu, C., Reverter, E., Martínez, J., Saliba, F., Jalan, R., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314240 · Cited by 572
Metadata
- Authors
- O'Brien, A. J., Fullerton, J. N., Massey, K. A., Auld, G., Sewell, G., James, S., Newson, J., Karra, E., Winstanley, A., Alazawi, W., Garcia-Martinez, R., Cordoba, J., Nicolaou, A., & Gilroy, D. W.
- Venue
- Nature Medicine
- Published
- 2014-04-13
- Volume
- 20
- Issue
- 5
- Pages
- 518-523
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1994460343
- Cited by
- 285
- References
- 39
- FWCI
- 10.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.